Last reviewed · How we verify
Off Metformin
At a glance
| Generic name | Off Metformin |
|---|---|
| Sponsor | German Diabetes Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer (PHASE2)
- Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma (PHASE2)
- ACTIV-6: COVID-19 Study of Repurposed Medications (PHASE3)
- The Combined Effect of N-Acetyl Cysteine and Metformin in Polycystic Ovary Syndrome Patients (PHASE3)
- A Pragmatic Approach to Lower Diabetes Risk After Gestational Diabetes (PHASE3)
- The Effect of Dapagliflozin on Weight Loss in Obese Adults Without Diabetes (PHASE4)
- Efficacy of Injectable Vitamin D Supplementation in Females With Polycystic Ovary Syndrome (PHASE1)
- "Hepatic Substrate Flux Rates in Type 2 Diabetes" (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Off Metformin CI brief — competitive landscape report
- Off Metformin updates RSS · CI watch RSS
- German Diabetes Center portfolio CI